Infectious entry of equine herpesvirus-1 into host cells through different endocytic pathways. Hasebe R, Sasaki M, Sawa H, Wada R, Umemura T, Kimura T. Virology. 393, 198-209, 2009.

Oseltamivir-resistant influenza A virus circulating in Japan. Tamura D, Mitamura K, Yamazaki M, Fujino M, Nirasawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Hiroi S, Takahasi K, Hata M, Minagawa H, Kimura Y, Kaneda S, Sugita S, Horimoto T, Sugaya N, Kawaoka Y. J. Clin. Microbiol. 47, 1424-1427, 2009.

Antibody responses induced by experimental West Nile virus infection with or without previous immunization with inactivated Japanese encephalitis vaccine in horses. Shirafuji H, Kanehira K, Kamio T, Kubo M, Shibahara T, Konishi M, Murakami K, Nakamura Y, Yamanaka T, Kondo T, Matsumura T, Muranaka M, Katayama Y. J. Vet. Med. Sci. 71, 969-974, 2009.

Cloning of the genome of equine herpesvirus 4 strain TH20p as an infectious bacterial artificial chromosome. Azab W, Kato K, Arii J, Tsujimura K, Yamane D, Tohya Y, Matsumura T, Akashi H. Arch. Virol. 154, 833-842, 2009.

Further development of an equine cell line that can be propagated over 100 times. Andoh K, Kai K, Matsumura T, Maeda K. J. Equine Sci. 20, 11-14, 2009.

Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses. Yamanaka T, Nemoto M, Tsujimura K, Kondo T, Matsumura T. Vet. Microbiol. 139, 351-355, 2009.

Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007). Perkins GA, Goodman LB, Tsujimura K, Van de Walle GR, Kim SG, Dubovi EJ, Osterrieder N, Vet. Microbiol. 139, 375-378, 2009.

Equine herpesvirus type 1 mutant defective in glycoprotein E gene as candidate vaccine strain. Tsujimura K, Shiose T, Yamanaka T, Nemoto M, Kondo T, Matsumura T. J. Vet. Med. Sci. 71, 1439-1448, 2009.

Estimation models for the morbidity of the horses infected with equine influenza virus. Sugita S, Oki H, Hasegawa T, Ishida N. J. Equine Sci. 19(3), 63-66, 2008.

Comparison of the growth kinetics of neuropathogenic and nonneuropathogenic equid herpesvirus type 1 (EHV-1) strains in cultured murine neuronal cells and the relevance of the D/N752 coding change in DNA polymerase gene (ORF30). Yamada S, Matsumura T, Tsujimura K, Yamaguchi T, Ohya K, Fukushi H. J. Vet. Med. Sci. 70(5), 505-511, 2008.

Evaluation of antigen detection kits for diagnosis of equine influenza. Yamanaka T, Tsujimura K, Kondo T, Matsumura T. Vet. Med. Sci. 70(2), 189-192, 2008.

Utilization of complement-dependent cytotoxicity to measure low levels of antibodies: Application to nonstructural protein 1 in a model of Japanese encephalitis virus. Konishi E, Kitai Y, Kondo T. Clin. Vaccine Immunol. 15(1), 88-94, 2008.

Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. Yamanaka T, Niwa H, Tsujimura K, Kondo T, Matsumura T. J. Vet. Med. Sci. 70(6), 623-625, 2008.

Application of enzyme-linked immunosorbent assays for the
diagnosis of emerging equine paramyxovirus infection. Shirai J, Matsumura T. Acta Vet. 57 (2-3), 143-155, 2007.

Molecular characterization of the equine herpesvirus 1 strains RacL 11 and Kentucky D.　Ghanen YM, Ibrahim EMS, Yamada S, Matsumura T, Osterrieder N, Yamaguchi T, Fukushi H, J Vet Med Sci. 69(5), 573-576, 2007.

Epitope-blocking enzyme-linked immunosorbent assay to differentiate West Nile virus from Japanese encephalitis virus infections in equine sera. Kitai Y, Shoda M, Kondo T, Konishi E. Clin Vaccine Immunol. 14(8), 1024-1031, 2007.

Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice. Ishikawa T, Takasaki T, Kurane I, Nukuzuma S, Kondo T, Konishi E. Microdes Infect. 9:1089-1095, 2007.

Detection of antibodies to equine arteritis virus in horse sera using recombinant chimaeric N/GL protein. Turan N, Ekici H, Yilmaz H, Kondo T, Hasoksuz M, Sato I, Tuchiya K, Fukunaga Y. Vet Rec. 161, 352-354, 2007.

Antibody Responses against American and European Lineage Strains of Equine-2 Influenza Virus among Racehorses Inoculated with the New Vaccine. Ohta M, Yamanaka T, Yoshinari M, Matsumura T. J Equine Sci. 18(3), 117-120, 2007.

Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models. Ttsujimura K, Yamanaka T, Kondo T, Fukushi H, Matsumura T. J Vet Med Sci. 68(10), 1029-1038, 2006.

Isolation and genetic analysis of Japanese encephalitis virus from a diseased horse in Japan. Yamanaka T, Tsujimura K, Kondo T, Yasuda W, Okada A, Noda K, Okumura T, Matsumura T. J Vet Med Sci. 68(3), 293-295, 2006.

Analysis of yearly changes in levels of antibodies to Japanese encephalitis virus nonstructural 1 protein in racehorses in central Japan shows high levels of natural virus activity still exist. Konishi E, Shoda M, Kondo T. Vaccine. 24, 516-524, 2006.

Detection of equine herpesvirus type 1 (EHV-1) DNA in organs of neonatal dead foals in Turkey. Tekelioglu BK, Matsumura T, Tsujimura K, Turan N, Ekici H, Yilmaz H. J Equine Sci. 17(1), 23-26, 2006.

In vitro efficacies of oseltamivir carboxylat.e and zanamivir against equine influenza viruses. Yamanaka T, Tsujimura K, Kondo T, Matsumura T. J Vet Med Sci. 68(4), 405-408. 2006.

Efficacy of oseltamivir phosphate to horses inoculated with equine influenza virus. Yamanaka T, Tsujimura K, Kondo T, Hobo S, Matsumura T. J Vet Med Sci. 68(9), 923-928. 2006.

Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination. Konishi E, Shoda M, Kondo T. Vaccine. 22, 1097-1103, 2004.

Development of an equine herpesvirus type 4-specific enzyme-linked immunosorbent assay using a B-cell epitope as an antigen. Maeda K, Mizukoshi F, Hamano M, Kai K, Iwata H, Kondo T, Matsumura T. J Clin Microbiol. 42(3), 1095-1098, 2004.

Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses. Konishi E, Shoda M, Ajiro N, Kondo T. J Clin Microbiol. 42(11), 5087-5093, 2004.

A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection. Kondo T, McGregor M, Chu Q, Chen D, Horimoto T, Kawaoka Y. Virology. 318, 414-419, 2004.

Meningoencephalitis in mice infected with an equine herpesvirus 1 strain KyA recombinant expressing glycoprotein I and glycoprotein. Frampton EAR Jr, Smith PM, Zhang Y, Grafton WD, Matsumura T, Osterrieder N, O'Callaghan DJ. Virus genes. 29(1), 9-17, 2004.

Growth and virulence alterations of equine herpesvirus 1 by insertion of a green fluorescent protein gene in the intergenic region between ORFs 62 and 63, EI. Ibrahim SM, Pagmajav O, Yamaguchi T, Matsumura T, Fukushi H. Microbiol Immunol. 48(11), 831-842, 2004.

Decreased expression of equine herpesvirus-1 early and late genes in the placenta of naturally aborted equine fetuses. Kimura T, Hasebe R, Mukaiya R, Ochiai K, Wada R, Umemura T. J Comp Path. 130, 41-47, 2004.

Detection of equine-2 influenza virus by the real time PCR. Sugita S, Matsumura T. J Equine Sci. 14(4), 111-117, 2003.

Genomic RNA constellation of recently emerging serotype G14 equine rotavirus strains in Japan that is highly homologous with prototype G3 and G14 strains previously identified in the United States of America. Nakagomi T, Tsunemitsu H, Imagawa H, Nakagomi O. Arch Virol. 148, 925-935, 2003.

Sero-epidemiological survey of equine rotavirus infections in 1-year-old Thoroughbred horses in the Hidaka region of Hokkaido. Imagawa H, Tsunemitsu H, Wada R, Fukunaga Y. J Equine Sci. 13 (2), 71-74, 2002.

Passage of equine herpesvirus-1 in suckling mouse brain enhances extraneural virus growth and subsequent hematogenous neuroinvasion. Hasebe R, Kimura T, Nakamura K, Okazaki K, Ochiai K, Wada R, Umemura T. J Vet Med Sci. 64(10), 907-912, 2002.

Equine herpesvirus-1-induced encephalomyelitis in mice: a comparative study of neuroadapted virus and its parental strain. Hasebe R, Kimura T, Sato E, Okazaki K, Ochiai K, Wada R, Umemura T. J Comp Path. 127, 118-125, 2002.

Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model. Frampton AR Jr, Smith PM, Zhang Y, Matsumura T, Osterrieder N, O'Callaghan DJ. Virus Res. 90, 287-301, 2002.

Serological diagnosis of equine influenza using the hemagglutinin protein produced in a baculovirus expression. Sugiura T, Sugita S, Imagawa H, Kanaya T, Ishiyama S, Saeki N, Uchiyama A, Tanigawa M, Kuwano A. J Virol Meth. 98, 1-8, 2001.

Predominance of G3B and G14 equine group A rotaviruses of a single VP4 serotype in Japan. Tsunemitsu H, Imagawa H, Togo M, Shouji T, Kawashima K, Horino R, Imai K, Nishimori T, Takagi M, Higuchi T. Arch Virol. 146, 1949-1962, 2001.

Getah virus. Kumanomido T. Encyclopedia of arthropod-transmitted infections of man and domestic animals. ed. Mike Service, CABI Publ. pp194-197, 2001.

Demonstration of equine herpesvirus-1 gene expression in the placental trophoblasts of naturally aborted equine fetuses. Mukaiya R, Kimura T, Ochiai K, Wada R, Umemura T. J Comp Path. 123, 119-125, 2000.

In vitro detection of equine arteritis from seminal plasma for idetification of carrier stallions. Fukunaga Y, Wada R, Sugita S, Fujita Y, Nambo Y, Imagawa H, Kenemaru T, Kamada M, Komatsu N, Akashi H. J Vet Med Sci. 62)6), 643-646, 2000.

Getah virus as an equine pathogen. Fukunaga Y, Kumanomido T, Kamada M. The Veterinary Clinics of North America, Equine Practice. 16(3), 605-61, 2000.

Identification of the products of the equine herpesvirus type 4 gI and gE genes. Damiani AM, Matsumura T, Jang H-K, Izumiya Y, Mikami T, Takahashi E. Arch Virol. 145, 1489-1496, 2000.

Application of a type-specific enzyme-linked immunosorbent assay for equine herpesvirus types 1 and 4 (EHV-1 and -4) to horse populations inoculated with inactivated EHV-1 vaccine. Yasunaga S, Maeda K, Matsumura T, Kondo T, Kai C. J Vet Med Sci. 62, 687-691, 2000.

A deletion in the gI and gE genes of equine herpesvirus type 4 reduces viral virulence in the natural host and affects virus transmission during cell-to-cell spread. Damiani AM, Matumura T, Yokoyama N, Mikami T, Takahashi E. Virus Res. 67, 189-202, 2000.